FOR IMMEDIATE RELEASE: 1 February 2023 CONTACTS: Hugill & Ip Solicitors Marco Raccuia, Head of Finance & Operations E-mail: marco.raccuia@hugillandip.com World Cancer Day – held every 4 February – is the global uniting initiative led by the Union for International Cancer Control (UICC). By raising worldwide awareness, improving education, and catalysing personal, collective and government action, UICC partners…...
Be a Spark of Hope for Cancer Patients – Renew Your Support Today!
As the year comes to a close, I wanted to reach out and ask for your support in our year-end fundraising campaign. Your generosity has the power to ignite a spark of hope for cancer patients and their families who are fighting an incredibly difficult battle. Your contribution will make a real difference…...
AFCR Annual Reception: A Community Effort to Find Cures for Cancer
On December 15, 2022, the Asian Fund for Cancer Research (AFCR) held its annual reception for community support of cancer research in Hong Kong. The event was a great success, thanks to the support of generous donors, attendees, and inspiring speakers who shared their thoughts on the importance of cancer…...
Cancer-Fighting Recipe: Vegetable Pho with Shiitake Mushrooms
Mushrooms are rich in vitamins, nutrients, and antioxidants. Recent research shows that these superfoods may also help guard against cancer. People who incorporated any variety of mushrooms into their daily diets had a lower risk of cancer. According to the findings, individuals who ate 18 grams of mushrooms daily had…...
94% of the U.S. population has been infected with the new coronavirus
By November 10, 2022, 94% (95% CrI, 79%-99%) of the US population were estimated to have been infected by SARS-CoV-2 at least once. Combined with vaccination, 97% (95%-99%) were estimated to have some prior immunological exposure to SARS-CoV-2. Between December 1, 2021 and November 10, 2022, protection against a new…...
Cancer Research Program Needs Your Help！
2022 has been a challenging year and filled with many distractions, and why I’m following up with you on an important update, I recently sent you. I hope you received the e-newsletter introducing AFCR’s Gastrointestinal cancers research and the exciting news that a new drug for Phase I clinical trial…...
